We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
This consultation closed on 20 November 2022.
We invited stakeholders to provide feedback on the draft guidance for ‘Boundary and combination products - medicines, medical devices, and biologicals’ to replace the existing guidance ‘Australian medical devices guidelines: 35. Device-medicine boundary products’.
The consultation was open for feedback from Friday 7 October 2022 to Sunday 20 November 2022 through an online survey hosted on the TGA Consultation Hub.
Outcome of the consultation
In total, 31 responses were received from stakeholders, including sponsors, manufacturers, peak industry bodies, regulatory affairs consultants, researchers, and health regulators.
A summary of responses and individual responses in accordance with respondent’s consent has been published on the Consultation Hub
In response to the feedback provided, we have updated our guidance and example list on boundary and combination products.
Next steps
We are undertaking another external consultation on proposal to legislate some boundary and combination products for additional clarity and transparency on the regulatory category.
Enquiries
For enquiries relating to the consultation or next steps, email devicereforms@tga.gov.au.